Quinazoline compounds for inducing degradation of kras g12d mutant protein
AL13611BActive Publication Date: 2026-09-23ASTELLAS PHARMA INC
0 Cites 0 Cited by
Patent Information
- Application Number
- AL2026275
- Authority / Receiving Office
- AL · AL
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2026-05-04
- Publication Date
- 2026-09-23
- Estimated Expiration
- 2046-05-04
Need to check novelty before this filing date? Find Prior Art
No text content released.